EyePoint Pharmaceuticals Reports Second Quarter 2019 Financial Results and Highlights Recent Company Progress

NEXT STORY
Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2019
PREV STORY
Sales of darolutamide started in the USA – Orion receives EUR 45 million milestone
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Turning Point Therapeutics Reports First-Quarter Financial Results, Provides Operational Updates

author_avatar
NASDAQ Market News

Chiasma to Host an Expert Panel on Acromegaly and the MPOWERED® Phase 3 Trial Results

author_avatar
NASDAQ Market News

Innate Pharma reports first half 2019 financial results and business update

author_avatar
NASDAQ Market News